These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 24987256)

  • 21. Mipomersen: evidence-based review of its potential in the treatment of homozygous and severe heterozygous familial hypercholesterolemia.
    Parhofer KG
    Core Evid; 2012; 7():29-38. PubMed ID: 22701100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autosomal recessive hypercholesterolemia: Case report.
    Petrulioniene Z; Gargalskaite U; Mikstiene V; Norvilas R; Skiauteryte E; Utkus A
    J Clin Lipidol; 2019; 13(6):887-893. PubMed ID: 31734096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Familial hypercholesterolemia: etiology, diagnosis and new treatment options.
    Gouni-Berthold I; Berthold HK
    Curr Pharm Des; 2014; 20(40):6220-9. PubMed ID: 24953396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disease control via intensified lipoprotein apheresis in three siblings with familial hypercholesterolemia.
    Taylan C; Schlune A; Meissner T; Ažukaitis K; Udink Ten Cate FE; Weber LT
    J Clin Lipidol; 2016; 10(6):1303-1310. PubMed ID: 27919346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current Approach to the Diagnosis and Treatment of Heterozygote and Homozygous FH Children and Adolescents.
    Cohen H; Stefanutti C;
    Curr Atheroscler Rep; 2021 May; 23(6):30. PubMed ID: 33963467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipoprotein apheresis and new therapies for severe familial hypercholesterolemia in adults and children.
    Page MM; Bell DA; Hooper AJ; Watts GF; Burnett JR
    Best Pract Res Clin Endocrinol Metab; 2014 Jun; 28(3):387-403. PubMed ID: 24840266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Just not cosmesis! Role of low-density lipoprotein apheresis in familial hypercholesterolemia: Experience at a newly developed tertiary care institution in Northern India.
    Kaur D; Negi G; Walia R; Malhotra S; Bhatia R; Meinia SK; Mandal S; Jain A
    Asian J Transfus Sci; 2021; 15(1):104-108. PubMed ID: 34349468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics and management of 1093 patients with clinical diagnosis of familial hypercholesterolemia in Greece: Data from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).
    Rizos CV; Elisaf MS; Skoumas I; Tziomalos K; Kotsis V; Rallidis L; Garoufi A; Athyros VG; Skalidis E; Kolovou G; Koutagiar I; Papagianni M; Antza C; Katsiki N; Ganotakis E; Liberopoulos EN
    Atherosclerosis; 2018 Oct; 277():308-313. PubMed ID: 30270064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial Hypercholesterolemia and Lipoprotein Apheresis.
    Makino H; Koezuka R; Tamanaha T; Ogura M; Matsuki K; Hosoda K; Harada-Shiba M
    J Atheroscler Thromb; 2019 Aug; 26(8):679-687. PubMed ID: 31231083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholesterol efflux mediators in homozygous familial hypercholesterolemia patients on low-density lipoprotein apheresis.
    Nenseter MS; Narverud I; Græsdal A; Bogsrud MP; Aukrust P; Retterstøl K; Ose L; Halvorsen B; Holven KB
    J Clin Lipidol; 2013; 7(2):109-16. PubMed ID: 23415429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic Review of Low-Density Lipoprotein Cholesterol Apheresis for the Treatment of Familial Hypercholesterolemia.
    Wang A; Richhariya A; Gandra SR; Calimlim B; Kim L; Quek RG; Nordyke RJ; Toth PP
    J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27385428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guidance for Pediatric Familial Hypercholesterolemia 2017.
    Harada-Shiba M; Ohta T; Ohtake A; Ogura M; Dobashi K; Nohara A; Yamashita S; Yokote K;
    J Atheroscler Thromb; 2018 Jun; 25(6):539-553. PubMed ID: 29415907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In pediatric familial hypercholesterolemia, lipoprotein(a) is more predictive than LDL-C for early onset of cardiovascular disease in family members.
    Zawacki AW; Dodge A; Woo KM; Ralphe JC; Peterson AL
    J Clin Lipidol; 2018; 12(6):1445-1451. PubMed ID: 30150142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic Management of Familial Hypercholesterolemia: Current and Emerging Drug Therapies.
    Patel RS; Scopelliti EM; Savelloni J
    Pharmacotherapy; 2015 Dec; 35(12):1189-203. PubMed ID: 26684558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The role of PCSK9-inhibitors and of lipoprotein apheresis in the treatment of homozygous and severe heterozygous familial hypercholesterolemia: A rivalry, or are things quite different?].
    Bláha V; Bláha M; Lánská M; Havel E; Vyroubal P; Zadák Z; Žák P
    Vnitr Lek; 2018; 64(1):43-50. PubMed ID: 29498875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnosis and treatment of familial hypercholesterolemia in Spain: Consensus document].
    Mata P; Alonso R; Ruiz A; Gonzalez-Juanatey JR; Badimón L; Díaz-Díaz JL; Muñoz MT; Muñiz O; Galve E; Irigoyen L; Fuentes-Jiménez F; Dalmau J; Pérez-Jiménez F
    Semergen; 2015; 41(1):24-33. PubMed ID: 25042971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up.
    Perez de Isla L; Alonso R; Watts GF; Mata N; Saltijeral Cerezo A; Muñiz O; Fuentes F; Diaz-Diaz JL; de Andrés R; Zambón D; Rubio-Marin P; Barba-Romero MA; Saenz P; Sanchez Muñoz-Torrero JF; Martinez-Faedo C; Miramontes-Gonzalez JP; Badimón L; Mata P;
    J Am Coll Cardiol; 2016 Mar; 67(11):1278-85. PubMed ID: 26988947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Guidelines for the management of familial hypercholesterolemia.
    Harada-Shiba M; Arai H; Oikawa S; Ohta T; Okada T; Okamura T; Nohara A; Bujo H; Yokote K; Wakatsuki A; Ishibashi S; Yamashita S
    J Atheroscler Thromb; 2012; 19(12):1043-60. PubMed ID: 23095242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lomitapide and mipomersen: novel lipid-lowering agents for the management of familial hypercholesterolemia.
    Dixon DL; Sisson EM; Butler M; Higbea A; Muoio B; Turner B
    J Cardiovasc Nurs; 2014; 29(5):E7-E12. PubMed ID: 24231894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What have we learned from Turkish familial hypercholesterolemia registries (A-HIT1 and A-HIT2)?
    Kayikcioglu M; Tokgozoglu L; Dogan V; Ceyhan C; Tuncez A; Kutlu M; Onrat E; Alici G; Akbulut M; Celik A; Yesilbursa D; Sahin T; Sonmez A; Ozdogan O; Temizhan A; Kilic S; Bayram F; Sabuncu T; Coskun FY; Ildizli M; Durakoglugil E; Kirilmaz B; Yilmaz MB; Yigit Z; Yildirim AB; Gedikli O; Topcu S; Oğuz A; Demir M; Yenerçağ M; Yıldırır A; Demircan S; Yilmaz M; Kaynar LG; Aktan M; Durmus RB; Gokce C; Ozcebe Oİ; Akyol TK; Okutan H; Sag S; Gul OO; Salcioglu Z; Altunkeser BB; Kuku I; Yasar HY; Kurtoglu E; Kose MD; Demircioglu S; Pekkolay Z; Ilhan O; Can LH
    Atherosclerosis; 2018 Oct; 277():341-346. PubMed ID: 30270069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.